T. E. Borovik

ASSOCIATION OF NUTRITIONAL STATUS AND MUCOACTIVE THERAPY REGIMEN WITH LUNG FUNCTION PARAMETERS IN CHILDREN WITH CYSTIC FIBROSIS AGED 6–17 YEARS RECEIVING ELEXACAFTOR/TEZACAFTOR/IVACAFTOR: A CROSS-SECTIONAL STUDY

Introduction: Cystic fibrosis is an autosomal recessive disease caused by mutations in the CFTR gene, leading to impaired ion transport, thickening of secretions, and damage to the bronchopulmonary system. Progressive mucoobstruction remains the leading cause of mortality. To improve sputum rheological properties, muco...